Company Operations by Product, Customer and Geographic Area

12 Months Ended

Dec. 31, 2015

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

NOTE 16 : Company Operations by Product, Customer and Geographic Area

The Company has determined that it operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer based technology. The Company's Chief Operating Decision Maker is the CEO. The CEO and the Board review profit and loss information on a consolidated basis to assess performance and make overall operating decisions as well as resource allocations. All products are included in one segment because the majority of our products have similar economic and other characteristics, including the nature of the products and production processes, type of customers, distribution methods and regulatory environment.

The following table presents a summary of total revenues by these products:

	Years Ended December 31,
	2015		2014		2013
Bloxiverz	$	150,283	$	10,211	$	-
Vazculep		20,151		-		-
Dextroamphetamine		1,946		1,643		-
Other		108		139		1,153
Total product sales and services		172,488		11,993		1,153
License and research revenue		721		2,782		3,026
Total revenues	$	173,209	$	14,775	$	4,179

The following table presents a summary of total revenues by significant wholesaler customer:

	Years Ended December 31,
	2015		2014		2013
Customer A	$	60,620	$	3,659	$	354
Customer B		53,988		3,937		541
Customer C		43,434		3,563		(124)
Other		14,446		834		382
Total product sales and services		172,488		11,993		1,153
License and research revenue		721		2,782		3,026
Total revenues	$	173,209	$	14,775	$	4,179

The following table summarizes revenues and non-monetary long-lived assets by geographic region. Non-monetary long-lived assets primarily consist of property and equipment, goodwill and intangible assets:

	2015		2014		2013
Revenues, for the years ended December 31,
United States	$	172,379	$	14,302	$	3,368
France		89		473		811
Ireland		741		-		-
Total	$	173,209	$	14,775	$	4,179
Long-lived assets, as of December 31,
United States	$	34,515	$	47,077	$	58,868
France		2,317		1,704		2,307
Ireland		258		-		-
Total	$	37,090	$	48,781	$	61,175